Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. (Q38433814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tiziana Martone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nicolò Roggero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Gabriele Brondino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Marco Pagano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Giorgio Cortesina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

1 reference

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

655-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315173%20AND%20SRC:MED&resulttype=core&format=json

HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma

26 December 2019

cites work

1 reference

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

21 January 2018

1 reference

Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model

21 January 2018

1 reference

Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry

21 January 2018

1 reference

Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck

21 January 2018

1 reference

7 January 2021

Prediction of survival in patients with head and neck cancer

1 reference

7 January 2021

Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging

1 reference

7 January 2021

Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines

1 reference

7 January 2021

Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations

1 reference

7 January 2021

Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas

1 reference

7 January 2021

The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma

1 reference

7 January 2021

Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome

1 reference

7 January 2021

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

1 reference

7 January 2021

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients

1 reference

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

7 January 2021

Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling.

1 reference

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

7 January 2021

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

1 reference

7 January 2021

Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival

1 reference

7 January 2021

A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas

1 reference

7 January 2021

Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer.

1 reference

7 January 2021

Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

1 reference

7 January 2021

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

7 January 2021

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

7 January 2021

Neck disease and distant metastases

1 reference

7 January 2021

Targeting epidermal growth factor receptor in head and neck cancer

1 reference

7 January 2021

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

1 reference

7 January 2021

Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas.

1 reference

7 January 2021

Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region

1 reference

7 January 2021

The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma

1 reference

7 January 2021

The role of epidermal growth factor receptor in head and neck squamous cell carcinoma

1 reference

7 January 2021

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

1 reference

7 January 2021

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

1 reference

7 January 2021

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

7 January 2021

Immunohistochemical localization of c-erbB-2 in human breast carcinomas

1 reference

7 January 2021

Oral cancer progression and c-erbB-2/neu proto-oncogene expression

1 reference

7 January 2021

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases

1 reference

7 January 2021